CRAIG WILLIAM S 4
4 · CADENCE PHARMACEUTICALS INC · Filed Aug 21, 2009
Insider Transaction Report
Form 4
Transactions
- Sale
Common stock
2009-08-20$10.19/sh−5,000$50,950→ 2,000 total - Exercise/Conversion
Common stock
2009-08-20$0.40/sh+5,000$2,000→ 7,000 total - Exercise/Conversion
Stock option (right to buy)
2009-08-20−5,000→ 67,500 totalExercise: $0.40From: 2005-02-16Exp: 2015-02-15→ common stock (5,000 underlying)
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2009.
- [F2]Not applicable to this transaction.